"Cytarabine" trang 1 - tải miễn phí từ tailieunhanh
Bortezomib prevents cytarabine resistance in MCL, which is characterized by downregulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

Bortezomib prevents cytarabine resistance in MCL, which is characterized by downregulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
17    29    1
Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid

Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
16    59    0
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study
8    82    0
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial

Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial
13    4    1
Human Developmental Toxicants

Human Developmental Toxicants
391    66    0
Báo cáo y học:

Báo cáo y học: "A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome"
36    72    0
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: A randomized controlled trial

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: A randomized controlled trial
8    49    1
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
13    63    1
Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death

Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death
15    43    1